- Home
- ZEUS vs RCKT Comparison
ZEUS vs RCKT Comparison
Compare ZEUS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEUS
- RCKT
- Stock Information
- Founded
- ZEUS 1954
- RCKT 1999
- Country
- ZEUS United States
- RCKT United States
- Employees
- ZEUS N/A
- RCKT N/A
- Industry
- ZEUS Metal Fabrications
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ZEUS Industrials
- RCKT Health Care
- Exchange
- ZEUS Nasdaq
- RCKT Nasdaq
- Market Cap
- ZEUS 352.6M
- RCKT 328.6M
- IPO Year
- ZEUS 1994
- RCKT N/A
- Fundamental
- Price
- ZEUS $33.71
- RCKT $3.28
- Analyst Decision
- ZEUS Buy
- RCKT Buy
- Analyst Count
- ZEUS 1
- RCKT 13
- Target Price
- ZEUS $38.00
- RCKT $12.96
- AVG Volume (30 Days)
- ZEUS 55.6K
- RCKT 6.0M
- Earning Date
- ZEUS 10-30-2025
- RCKT 08-07-2025
- Dividend Yield
- ZEUS 1.90%
- RCKT N/A
- EPS Growth
- ZEUS N/A
- RCKT N/A
- EPS
- ZEUS 1.23
- RCKT N/A
- Revenue
- ZEUS $1,878,204,000.00
- RCKT N/A
- Revenue This Year
- ZEUS $0.48
- RCKT N/A
- Revenue Next Year
- ZEUS $2.77
- RCKT $108.43
- P/E Ratio
- ZEUS $27.48
- RCKT N/A
- Revenue Growth
- ZEUS N/A
- RCKT N/A
- 52 Week Low
- ZEUS $26.32
- RCKT $2.19
- 52 Week High
- ZEUS $43.60
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- ZEUS 58.07
- RCKT 51.17
- Support Level
- ZEUS $33.15
- RCKT $2.88
- Resistance Level
- ZEUS $34.07
- RCKT $3.74
- Average True Range (ATR)
- ZEUS 0.81
- RCKT 0.27
- MACD
- ZEUS 0.23
- RCKT 0.02
- Stochastic Oscillator
- ZEUS 86.91
- RCKT 35.43
About ZEUS Olympic Steel Inc.
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.